Clinical Trials Browser

Phase 2 × 4,17 beta-dihydroxy-4-androstene-3-one × 1 year × Clear all

NCT04009044 2025-10-09

Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast

Phase 2 Active not recruiting

Carcinoma, Intraductal, Noninfiltrating